KCT0007273
Recruiting
未知
A 8 week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of CAEC on Immune Function
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- AEKYUNG Industry
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Male or female subjects aged from 30 to 70 years old.
- •2\) White blood cell (WBC) ranged from 4000 to 8000 cells/ul at visit 1\.
- •3\) Perceived stress scale (PSS) above 16 score.
- •4\) Subjects who agreed to participate in this study and subjects who signed written informed consent voluntarily.
Exclusion Criteria
- •1\) Subjects who currently taking medications for an underlying disease, etc
- •2\) Hypertension (systolic blood pressure above 140mmHg or diastolic blood pressure above 90mmHg, after 10 minutes of rest)
- •3\) Diabetes (FBS(fasting blood sugar) level greater than 126 mg/dl or taking drugs due to diabetes)
- •4\) TSH below 0\.1µIU/mL or above 10µIU/mL
- •5\) Vaccinated within 3 months before visit1 (influenza, COVID\-19, herpes zoster, etc.)
- •6\) Patients with diseases that can affect the immune response, such as adult asthma and rhinitis
- •7\) Before visit 1, donate whole blood within 2 months or donate component blood within 4 weeks person who performed
- •8\) AST(aspartate aminotransferase) or ALT(alanine aminotransferase) is more than 3 times the normal upper limit
- •9\) Creatinine blood level is more than 1\.5 times the normal upper limit
- •10\) Subjects who have used steroids within 1 month based on visit 1
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A Clinical Trial for the Evaluation of the Efficacy and Safety of Platycodon grandiflorum extract mixture on improvement on stressFactors influencing health status and contact with health servicesKCT0007161Sungkyunbiotech150
Recruiting
Not Applicable
A 8 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of HDB1258 on Improving Immune FunctioNot ApplicableKCT0008204Seoul National University Bundang Hospital100
Completed
Not Applicable
A 8 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of NVP-1905 on Menopausal Symptoms of WomeDiseases of the genitourinary systemKCT0009162Soonchunhyang University Medical Center130
Recruiting
Not Applicable
Clinical Trial for the Evaluation of the Efficacy and Safety of AGE on Reducing Serum Uric AcidKCT0005388H Plus Yangji Hospital56
Completed
Not Applicable
A 8 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of OFE on Memory Improvement of AdolescentNot ApplicableKCT0008170Konkuk University Medical Center56